The New York Times has produced, often on its Prescriptions or Economix blogs, several useful summaries of health care systems in other countries. However, today’s front page contains an editorial in the guise of news entitled, Swiss Health Care Thrives Without Public Option, which illustrates a point I’ve been making.

The Swiss system, reporter Nelson Schwartz informs us, provides quality, universal coverage, but thankfully avoids being "bureaucratic, socialized medicine." What a relief. The Times then invites us to view the Swiss system as a model for the US:

Swiss private insurers are required to offer coverage to all citizens, regardless of age or medical history. And those people, in turn, are obligated to buy health insurance.

That is why many academics who have studied the Swiss health care system have pointed to this Alpine nation of about 7.5 million as a model that delivers much of what Washington is aiming to accomplish — without the contentious option of a government-run health insurance plan.

The slam on a public option is both gratuitous and irrelevant, given the Swiss system. As I discussed in this post, When Is a Regulatory Scheme Equivalent to A Government-Run System?, a pervasive regulatory scheme that controls the key elements of an insurance system can become equivalent to an explicit government insurance system.

More important, you have to have at least one or the other (and possibly both?) to succeed. Our Senate isn’t proposing either approach for insurers in exchange markets, but both conditions exist in Medicare. That’s why virtually all Congressional proposals for controlling costs are focused on Medicare (and using Medicare’s leverage to affect provider costs); without a Public Option to push cost reforms, there’s no mechanism to achieve cost reductions in the Exchange, and only a high-end insurance tax to indirectly affect costs in the employer-based market.

And sure enough, the Times article eventually hints at which of these two approaches the Swiss use:

The Swiss government does not “ration care” — that populist bogeyman in the American debate — but it does keep down overall spending by regulating drug prices and fees for lab tests and medical devices. It also requires patients to share some costs — at a higher level than in the United States — so they have an incentive to avoid unnecessary treatments. And some doctors grumble that cost controls are making it harder these days for a physician to make a franc.

There are other important details, but it turns out the Swiss achieve quality and lower costs not through competition between the many non-profit insurers in each Canton, but because there’s a pervasive national system of government regulation with price and quality controls, along with a government-defined framework of basic insurance plans.

The Times’ cites Harvard’s Regina Herzlinger, an expert who attributes the Swiss success to its customer-driven, competitive attributes. These are just the things to appeal to certain Senate Finance Committee members.

“What I like about it is that it’s got universal coverage, it’s customer driven, and there are no intermediaries shopping on people’s behalf,” she added. “And there’s no waiting lists or rationing.”

It would have been helpful if the Times had also checked with Princeton’s Uwe Reinhardt, who has also written on the Swiss system and, moreover, reviewed Herzlinger’s study.* Reinhardt writes a weekly post for the Times Economix blog on, among other things, international health care systems. According to Reinhardt,

On the surface, the Swiss health system may give the impression of a price-competitive, consumer-directed health care model. However, the heavy government regulation that pervades the entire system — including the health insurance sector — makes it a far cry from the vigorous, price-competitive health care market envisaged by the advocates of consumer-directed health plans in the United States. Some gestures to competition aside, the Swiss system so far has remained mainly a de facto cartel of insurers and health care practitioners who transact with one another in a tight web of government regulations. . . .

But who brings about the lower prices of health care in the Swiss health system? Herzlinger and Parsa-Parsi[fn] argue that these prices reflect the consumers’ idea of “value for the money.” However, the insured in Switzerland have only indirect and probably weak influence over the prices paid to clinicians, as these prices are negotiated by the cartel-like associations of insurers and clinicians under the watchful eye and heavy hand of government. Since all insurers are bound to the same prices for ambulatory care and prices are negotiated between insurers and individual hospitals for inpatient care, it is not clear how effectively consumer choice among insurers can influence the prices paid to clinicians. It can just as plausibly be argued that these prices reflect government’s idea of value for the money. . . .

Finally, what is most impressive about the Swiss health system is the role tight government regulation plays throughout the entire system. One can plausibly argue that this regulation is chiefly responsible for both the high quality and (relative to the United States) low cost of Swiss health care. Absent that regulation, the Swiss health system probably would metamorphose into something resembling the much less regulated, high-cost US system, which is both more inefficient and more inequitable than the Swiss system, as Herzlinger and Parsa-Parsi take pains to point out.

So the Times headline is not only gratuitous, it misses the point. Once again, we find that where there is no explicit government insurance system as France has, success depends on a pervasive national regulatory scheme, including close rate regulation of drugs, devices, provider services and insurance, which is far beyond anything proposed by Congress.

Our Senate sees only what it wants to see — "It’s not socialism! There’s no PO!" — but they ignore the features that substitute and produce the favored results. The Times editors should be helping them see the whole picture.

*Uwe E. Reinhart, The Swiss Health System, JAMA (2004) See pdf link here.

More
:
See wesgpc, comment #1 below for links to WHO descriptions of Swiss system:
http://www.euro.who.int/document/e68670.pdf
http://www.euro.who.int/observatory
More Swiss links from commenter RainaP here.